BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

PharmaSeq Incorporated

PharmaSeq, Inc. is a genomics company that has developed the world's first light-powered microtransponders and nanotransponders for performing nucleic acid-based assays. It is a privately held biotechnology company with corporate headquarters and research and development facilities near Princeton, NJ. The Company has eight U.S. patents covering microtransponder-based assays and technology and several more patents pending. PharmaSeq's strategy is to apply microtransponder technology to DNA probe diagnostics, single nucleotide polymorphism (SNP) detection, and proteomics. The Company will then move forward in other aspects of genomics, as well as pharmaceutical drug discovery, combinatorial chemistry, radio frequency identification (RFID) and related areas.


Contact Details:
1 Deer Park Drive, Suite F
Monmouth Junction
NJ
08852
United States of America
Tel:(732) 355-0100
Fax:(732) 355-0102
Email:mandecki@pharmaseq.com
WWW:

www.pharmaseq.com/




Loading...

Recent Publications by PharmaSeq Incorporated:

Microtransponder-based multiplex assay for genotyping cystic fibrosis.
BACKGROUND: We developed and evaluated a genotyping assay for detection of...
19th September, 2007
PharmaSeq, Inc., Monmouth Junction, NJ 08852, USA. Clin Chem. 2007 Jul;53(7):1372-6. Epub 2007 May 17.
DOI Direct Link
Microtransponders, the miniature RFID electronic chips, as platforms for cell growth in cytotoxicity assays.
BACKGROUND: An electronic radio frequency (RF) microchip, the...
12th December, 2006
PharmaSeq, Inc., Monmouth Jct., New Jersey 08852, USA. Cytometry A. 2006 Nov 1;69(11):1097-105.
DOI Direct Link

PharmaSeq Incorporated Patents:

US Patent No.Title
7098394 Method and apparatus for powering circuitry with on-chip solar cells within a common substrate
6387623 Screening of drugs from chemical combinatorial libraries employing transponders
6376187 Electronically-indexed solid-phase assay for biomolecules
6361950 Multiplex assay for nucleic acids employing transponders
6051377 Multiplex assay for nucleic acids employing transponders

View more PharmaSeq Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 357 times since April 2007, the link to the organisation's website has been followed 69 times

Recent Search Terms used to find this page: drug development company, Monmouth Junction, NJ | companies in Monmouth | pharmaseq nj | pharmaseq | pharmaseq | pharmaseq website | pharmaseq website | @ pharmaseq.com | f | microtransponder -verichip -implantable | .

Search for more companies in Monmouth Junction

Search for more companies in NJ



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for PharmaSeq Incorporated
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.